Medivolve Announces Change of Auditor and Board Changes
November 16 2023 - 7:00PM
Medivolve Inc. (“
Medivolve” or the
“
Company”) (NEO: MEDV; OTC: MEDVF; FRA:4NC)
announces that it has changed auditors from McGovern Hurley LLP
(“
McGovern”) to MNP LLP (“
MNP”),
effective November 9, 2023. At the request of the Company, McGovern
has resigned as of the effective date of November 9, 2023. MNP has
been appointed as the successor auditor. In accordance with
National Instrument 51‐102 (“
NI 51‐102”), the
Company has filed a Change of Auditor Notice on SEDAR together with
letters from both McGovern and MNP, with each letter confirming
agreement with the statements contained in the notice, as
applicable. There were no reportable events (as defined in NI
51‐102) between McGovern and the Company.
In addition, the Company announced today that
Wen Ye has resigned from its board of directors, effective
immediately. Management and the board would like to thank Ms. Ye
for her services and extensive contributions to the Company and
wish her well in her future endeavours.
About Medivolve, Inc.
Medivolve Inc. is a Canadian
healthcare technology company headquartered in Toronto, Canada. The
Company’s mission is to improve health and lives by delivering
world-class diagnostic solutions—starting with COVID-19—as well as
to enable faster and better care to patients through innovative
technology. Medivolve, through its subsidiaries, operates retail
patient-care locations in California.
For investing inquiries, please
contact: David Preiner, CEO, info@medivolve.ca,
702-990-3737.
Medivolve (NEO:MEDV)
Historical Stock Chart
From Oct 2024 to Nov 2024
Medivolve (NEO:MEDV)
Historical Stock Chart
From Nov 2023 to Nov 2024